Substituted 1-alkylcinnolin-4(1H)-one derivatives, preparation thereof and therapeutic application of same
    6.
    发明授权
    Substituted 1-alkylcinnolin-4(1H)-one derivatives, preparation thereof and therapeutic application of same 有权
    取代的1-烷基噌啉-4(1H) - 酮衍生物,其制备方法及其治疗应用

    公开(公告)号:US08420651B2

    公开(公告)日:2013-04-16

    申请号:US13262869

    申请日:2010-04-06

    IPC分类号: A61K31/50 A61K31/501

    CPC分类号: C07D237/28

    摘要: The subject of the present invention is compounds corresponding to the formula (I) in which: X represents a divalent (C2-C5)alkylene radical which is unsubstituted or substituted one or more times by an Alk group; R1 represents a phenyl, a naphthyl, a pyridyl, a 1-benzothienyl or a 1,3-benzodioxolyl; R2 represents a hydrogen atom, a halogen atom, an Alk group, an OAlk group or else a group chosen from —S-Alk, —SO-Alk, —SO2-Alk, —CO—N(R4)-Alk, —N(R4)SO2-Alk, —N(R4)CO-Alk, —N(R4)SO2—N(Alk)2; R3 represents a hydrogen atom, a halogen atom, an Alk group or an OAlk group; R4 represents a hydrogen atom or a (C1-C4)alkyl; Alk represents an unsubstituted or substituted (C1-C4)alkyl. Preparation process and therapeutic application.

    摘要翻译: 本发明的主题是对应于式(I)的化合物,其中:X表示未被取代或被Alk基取代一次或多次的二价(C 2 -C 5)亚烷基; R 1表示苯基,萘基,吡啶基,1-苯并噻吩基或1,3-苯并二恶唑基; R 2表示氢原子,卤素原子,Alk基团,OAlk基团或选自-S-Alk,-SO-Alk,-SO 2 -Alk,-CO-N(R 4)-Alk,-N (R4)SO2-Alk,-N(R4)CO-Alk,-N(R4)SO2-N(Alk)2; R 3表示氢原子,卤素原子,Alk基团或OAlk基团; R4表示氢原子或(C1-C4)烷基; Alk表示未取代或取代的(C1-C4)烷基。 制备工艺及治疗应用。

    SUBSTITUTED 1-ALKYLCINNOLIN-4(1H)-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION OF SAME
    7.
    发明申请
    SUBSTITUTED 1-ALKYLCINNOLIN-4(1H)-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION OF SAME 有权
    取代的1-烷基喹啉-4-(1H) - 酮衍生物,其制备方法及其相应的应用

    公开(公告)号:US20120129864A1

    公开(公告)日:2012-05-24

    申请号:US13262869

    申请日:2010-04-06

    CPC分类号: C07D237/28

    摘要: The subject of the present invention is compounds corresponding to the formula (I) in which: X represents a divalent (C2-C5)alkylene radical which is unsubstituted or substituted one or more times by an Alk group; R1 represents a phenyl, a naphthyl, a pyridyl, a 1-benzothienyl or a 1,3-benzodioxolyl; R2 represents a hydrogen atom, a halogen atom, an Alk group, an OAlk group or else a group chosen from —S-Alk, —SO-Alk, —SO2-Alk, —CO—N(R4)-Alk, —N(R4)SO2-Alk, —N(R4)CO-Alk, —N(R4)SO2—N(Alk)2; R3 represents a hydrogen atom, a halogen atom, an Alk group or an OAlk group; R4 represents a hydrogen atom or a (C1-C4)alkyl; Alk represents an unsubstituted or substituted (C1-C4)alkyl. Preparation process and therapeutic application.

    摘要翻译: 本发明的主题是对应于式(I)的化合物,其中:X表示未被取代或被Alk基取代一次或多次的二价(C 2 -C 5)亚烷基; R 1表示苯基,萘基,吡啶基,1-苯并噻吩基或1,3-苯并二恶唑基; R 2表示氢原子,卤素原子,Alk基团,OAlk基团或选自-S-Alk,-SO-Alk,-SO 2 -Alk,-CO-N(R 4)-Alk,-N (R4)SO2-Alk,-N(R4)CO-Alk,-N(R4)SO2-N(Alk)2; R 3表示氢原子,卤素原子,Alk基团或OAlk基团; R4表示氢原子或(C1-C4)烷基; Alk表示未取代或取代的(C1-C4)烷基。 制备工艺及治疗应用。

    Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
    10.
    发明申请
    Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics 失效
    吲哚-3-甲酰胺的衍生物,其制备方法及其在治疗中的应用

    公开(公告)号:US20050288356A1

    公开(公告)日:2005-12-29

    申请号:US11138843

    申请日:2005-05-26

    CPC分类号: C07D209/42

    摘要: The invention relates to derivatives of indole-3-carboxamide having general formula (I): wherein: R1 represents a C3-C10 alkyl, a C5-C10 carbocyclic radical that is unsubstituted or substituted one or more times with a methyl group; R2 represents a hydrogen atom or a (C1-C4)alkyl group; R3 represents a halogen atom or a (C1-C4)alkyl group; R4 represents a hydrogen or halogen atom or a (C1-C4)alkyl group; R5 represents a (C1-C4)alkyl group or a trifluoromethyl; X represents a sulfur atom, an —NHSO2— group or an —SO2— group; and n is equal to 2 or 3. The invention also relates to a method of preparing the aforementioned derivatives and to the application of same in therapeutics.

    摘要翻译: 本发明涉及具有通式(I)的吲哚-3-甲酰胺的衍生物:其中:R 1表示C 3 -C 10烷基, 烷基,未被取代或被甲基取代一次或多次的C 5 -C 10 -C 10碳环基团; R 2表示氢原子或(C 1 -C 4 -C 4)烷基; R 3表示卤素原子或(C 1 -C 4 -C 4)烷基; R 4表示氢或卤素原子或(C 1 -C 4 -C 4)烷基; R 5表示(C 1 -C 4 -C 4)烷基或三氟甲基; X表示硫原子,-NHSO 2 - 或-SO 2 - ; - 并且n等于2或3.本发明还涉及制备上述衍生物的方法及其在治疗中的应用。